-
公开(公告)号:US08703192B2
公开(公告)日:2014-04-22
申请号:US12385280
申请日:2009-04-03
申请人: Isabel Anstett-Klein , Rango Dietrich , Hartmut Ney , Marc Schiller , Sabine Schaefer-Preuss , Manfred Hartmann
发明人: Isabel Anstett-Klein , Rango Dietrich , Hartmut Ney , Marc Schiller , Sabine Schaefer-Preuss , Manfred Hartmann
IPC分类号: A61K9/22
CPC分类号: A61K9/2886 , A61K9/2081 , A61K9/5078 , A61K31/44 , A61K31/4439
摘要: Dosage forms for the oral administration of the magnesium salt of pantoprazole are described.
摘要翻译: 描述了口服泮托拉唑镁盐的剂型。
-
2.Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles 失效
标题翻译: 吡啶-2-基甲基亚磺酰基-1H-苯并咪唑的口服给药形式公开(公告)号:US20080226712A1
公开(公告)日:2008-09-18
申请号:US12153585
申请日:2008-05-21
申请人: Rango Dietrich , Hartmut Ney
发明人: Rango Dietrich , Hartmut Ney
IPC分类号: A61K9/58 , A61K31/4439 , A61K9/54
CPC分类号: A61K9/2027 , A61K9/2846
摘要: The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is provided with a film coating customary per se for sustained-release compositions.
摘要翻译: 本发明涉及吡啶-2-基甲基亚磺酰基-1H-苯并咪唑及其盐的口服给药形式,其包含活性化合物和片剂崩解剂,并且为缓释组合物提供本身常用的薄膜包衣。
-
公开(公告)号:US20080102133A1
公开(公告)日:2008-05-01
申请号:US11663994
申请日:2005-09-30
CPC分类号: A61K31/4439 , A61K9/0056 , A61K9/2081 , A61K9/2095 , A61K9/5026 , A61K9/5078 , A61K31/4375
摘要: The invention relates to novel dosage forms for proton pump antagonists.
摘要翻译: 本发明涉及质子泵拮抗剂的新型剂型。
-
4.Oral Pharmaceutical Preparation Comprising a Proton Pump Antagonist and a Basic Excipient 审中-公开
标题翻译: 包含质子泵拮抗剂和碱性赋形剂的口服药物制剂公开(公告)号:US20080050428A1
公开(公告)日:2008-02-28
申请号:US11663998
申请日:2005-09-30
IPC分类号: A61K31/4375 , A61K9/20 , A61P1/04
CPC分类号: A61K31/4375
摘要: The invention relates to novel extended release dosage forms for reversible proton pump antagonists comprising a basic excipient.
摘要翻译: 本发明涉及包含碱性赋形剂的可逆质子泵拮抗剂的新型延长释放剂型。
-
5.Oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles 失效
标题翻译: 吡啶-2-基甲基亚磺酰基-1H-苯并咪唑的口服给药形式公开(公告)号:US07041313B1
公开(公告)日:2006-05-09
申请号:US09762302
申请日:1999-08-07
申请人: Rango Dietrich , Hartmut Ney
发明人: Rango Dietrich , Hartmut Ney
CPC分类号: A61K9/2027 , A61K9/2846
摘要: The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is provided with a film coating customary per se for sustained-release compositions.
摘要翻译: 本发明涉及吡啶-2-基甲基亚磺酰基-1H-苯并咪唑及其盐的口服给药形式,其包含活性化合物和片剂崩解剂,并且为缓释组合物提供本身常用的薄膜包衣。
-
公开(公告)号:US08758817B2
公开(公告)日:2014-06-24
申请号:US13069584
申请日:2011-03-23
申请人: Rango Dietrich , Isabel Anstett-Klein , Marc Schiller , Hartmut Ney , Manfred Hartmann , Sabine Schäfer-Preuss
发明人: Rango Dietrich , Isabel Anstett-Klein , Marc Schiller , Hartmut Ney , Manfred Hartmann , Sabine Schäfer-Preuss
IPC分类号: A61K9/22
CPC分类号: A61K9/2886 , A61K9/2081 , A61K9/2846 , A61K9/5073 , A61K9/5078 , A61K31/4439
摘要: Dosage forms for oral administration of the magnesium salt of (S)-pantoprazole are described.
摘要翻译: 描述了用于口服施用(S) - 吡那唑的镁盐的剂型。
-
7.Oral administration form for pyridin-2-ylmethylsulfinyl-1H benzimidazoles 失效
标题翻译: 吡啶-2-基甲基亚磺酰基-1H-苯并咪唑的口服给药形式公开(公告)号:US08465767B2
公开(公告)日:2013-06-18
申请号:US12153585
申请日:2008-05-21
申请人: Rango Dietrich , Hartmut Ney
发明人: Rango Dietrich , Hartmut Ney
IPC分类号: A61K9/58 , A61K9/54 , A61K31/4439
CPC分类号: A61K9/2027 , A61K9/2846
摘要: The invention relates to an oral administration form for pyridin-2-ylmethylsulfinyl-1H-benzimidazoles and their salts, which comprises the active compound together with tablet disintegrants and is provided with a film coating customary per se for sustained-release compositions.
摘要翻译: 本发明涉及吡啶-2-基甲基亚磺酰基-1H-苯并咪唑及其盐的口服给药形式,其包含活性化合物和片剂崩解剂,并且为缓释组合物提供本身常用的薄膜包衣。
-
8.Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidone as excipient 有权
标题翻译: 含有PDE4抑制剂作为活性成分和聚乙烯吡咯烷酮作为赋形剂的口服剂型公开(公告)号:US08431154B2
公开(公告)日:2013-04-30
申请号:US13008842
申请日:2011-01-18
申请人: Rango Dietrich , Klaus Eistetter , Hartmut Ney
发明人: Rango Dietrich , Klaus Eistetter , Hartmut Ney
IPC分类号: A61K9/20
CPC分类号: A61K9/0002 , A61K9/0053 , A61K9/20 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2054 , A61K9/2059 , A61K31/166 , A61K31/44
摘要: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
摘要翻译: 描述了用于口服施用其溶解度小的PDE 4抑制剂的剂型。 它们含有PVP作为粘合剂。
-
9.Oral Dosage Form Containing A PDE 4 Inhibitor As An Active Ingredient And Polyvinylpyrrolidone As Excipient 有权
标题翻译: 含有作为活性成分的PDE 4抑制剂和作为赋形剂的聚乙烯吡咯烷酮的口服剂型公开(公告)号:US20110251244A1
公开(公告)日:2011-10-13
申请号:US13008842
申请日:2011-01-18
申请人: Rango Dietrich , Hartmut Ney , Klaus Eistetter
发明人: Rango Dietrich , Hartmut Ney , Klaus Eistetter
CPC分类号: A61K9/0002 , A61K9/0053 , A61K9/20 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2054 , A61K9/2059 , A61K31/166 , A61K31/44
摘要: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
摘要翻译: 描述了用于口服施用其溶解度小的PDE 4抑制剂的剂型。 它们含有PVP作为粘合剂。
-
10.Oral dosage form containing a PDE 4 inhibitor as an active ingredient and polyvinylpyrrolidon as excipient 有权
标题翻译: 含有PDE4抑制剂作为活性成分和聚乙烯吡咯烷酮作为赋形剂的口服剂型公开(公告)号:US07951397B2
公开(公告)日:2011-05-31
申请号:US10505138
申请日:2003-02-19
申请人: Rango Dietrich , Klaus Eistetter , Hartmut Ney
发明人: Rango Dietrich , Klaus Eistetter , Hartmut Ney
IPC分类号: A61K9/20
CPC分类号: A61K9/0002 , A61K9/0053 , A61K9/20 , A61K9/2013 , A61K9/2018 , A61K9/2027 , A61K9/2054 , A61K9/2059 , A61K31/166 , A61K31/44
摘要: Dosage forms for oral administration of a PDE 4 inhibitor whose solubility is slight are described. They contain PVP as binder.
摘要翻译: 描述了用于口服施用其溶解度小的PDE 4抑制剂的剂型。 它们含有PVP作为粘合剂。
-
-
-
-
-
-
-
-
-